Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The development of clinical research in CRC.
Labianca R, Beretta GD, Mosconi S, Pessi MA, Milesi L. Labianca R, et al. Among authors: pessi ma. Ann Oncol. 2005 May;16 Suppl 4:iv37-43. doi: 10.1093/annonc/mdi906. Ann Oncol. 2005. PMID: 15923427 Free article. Review. No abstract available.
Colorectal cancer: screening.
Labianca R, Beretta GD, Mosconi S, Milesi L, Pessi MA. Labianca R, et al. Among authors: pessi ma. Ann Oncol. 2005;16 Suppl 2:ii127-32. doi: 10.1093/annonc/mdi730. Ann Oncol. 2005. PMID: 15958442 Free article. Review. No abstract available.
The role of adjuvant chemotherapy in colon cancer.
Labianca R, Milesi L, Mosconi S, Pessi MA, Beretta GD, Quadri A. Labianca R, et al. Among authors: pessi ma. Surg Oncol. 2007 Dec;16 Suppl 1:S93-6. doi: 10.1016/j.suronc.2007.10.042. Surg Oncol. 2007. PMID: 18257148 Review.
Is there an advantage for oral therapy in elderly? UFT.
Labianca R, Beretta G, Mosconi S, Pessi MA. Labianca R, et al. Among authors: pessi ma. Tumori. 2002 Jan-Feb;88(1 Suppl 1):S71-2. doi: 10.1177/030089160208800121. Tumori. 2002. PMID: 11989931 No abstract available.
Colon cancer.
Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, de Braud F, Wils J. Labianca R, et al. Among authors: pessi ma. Crit Rev Oncol Hematol. 2010 May;74(2):106-33. doi: 10.1016/j.critrevonc.2010.01.010. Crit Rev Oncol Hematol. 2010. PMID: 20138539 Review.
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Cascinu S, Frontini L, Labianca R, Catalano V, Barni S, Graiff C, Picone G, Farinati E, Zonato S, Pessi MA, Curti C, Catalano G. Cascinu S, et al. Among authors: pessi ma. Ann Oncol. 2000 Oct;11(10):1309-11. doi: 10.1023/a:1008393010472. Ann Oncol. 2000. PMID: 11106121 Free article.
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.
Sobrero A, Zaniboni A, Frassineti GL, Aschele C, Guglielmi A, Giuliani R, Ravaioli A, Lanfranco C, Caroti C, Arnoldi E, Barni S, Gallo L, Pessi MA, Turci D, Cortesi E, Grossi F, Frontini L, Piazza E, Bruzzi P, Labianca R. Sobrero A, et al. Among authors: pessi ma. Ann Oncol. 2000 Nov;11(11):1413-20. doi: 10.1023/a:1026527605389. Ann Oncol. 2000. PMID: 11142481 Free article. Clinical Trial.
34 results